Full-Time

UI/UX Designer

Confirmed live in the last 24 hours

Twist Bioscience

Twist Bioscience

1,001-5,000 employees

Produces synthetic DNA for biotechnology applications

Compensation Overview

$124.7k - $141k/yr

+ Bonus + Equity

Mid, Senior

San Bruno, CA, USA

Hybrid position requiring in-office presence in South San Francisco, CA.

Category
Product & UX/UI Design
UI/UX & Design
Required Skills
Agile
UI/UX Design
Figma
Requirements
  • Bachelor's degree and a minimum of 3+ years of experience designing elegant, powerful UIs
  • Experience designing sophisticated UIs using collaborative tools such as Figma or similar platform
  • Strong knowledge and opinions about good UI/UX practices and a commitment to delivering user satisfaction
  • Self-starter with a strong work ethic
  • Familiarity with software development methodologies, principles and procedures, and related software management tools.
Responsibilities
  • Work with stakeholders and developers to design and define user-friendly and intuitive UIs and UX flows lab management systems.
  • Participate in requirements gathering, technical specification, and the design and development of UIs for Twist’s suite of services.
  • Gather requirements and workshop with stakeholders to drive new UIs and continuously improve existing UIs
  • Agile, iterative development workflow with continuous delivery.
Desired Qualifications
  • Experience with HTML5, CSS3, and JavaScript a plus
  • Experience with technical or manufacturing UIs is preferred

Twist Bioscience specializes in the synthesis of synthetic DNA, which is essential for various applications in biotechnology, pharmaceuticals, and research. The company produces high-quality DNA sequences that clients, including academic institutions and pharmaceutical companies, use for drug development, disease diagnosis, and genetic research. Twist Bioscience differentiates itself by offering competitive pricing and a proprietary platform that enables quick and accurate DNA production. This platform uses an algorithm to provide instant feedback on the synthesizability of DNA sequences. Their product range includes genes, oligo pools, variant libraries, and tools for SARS-CoV-2, along with DNA data storage and next-generation sequencing services. The company's goal is to be a leading supplier in the synthetic biology market, providing thousands of genes rapidly and supporting complex research projects.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

South San Francisco, California

Founded

2013

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Absci enhances capabilities in AI-driven therapeutic antibody discovery.
  • Atlas Data Storage spin-out opens new revenue streams in DNA-based data storage.
  • Partnership with MedGenome expands reach into healthcare diagnostics for rare diseases.

What critics are saying

  • Atlas spin-out may divert focus from core synthetic DNA business.
  • Generative AI collaboration with Absci could face performance challenges, delaying product development.
  • Stock sale by president might signal lack of confidence in short-term performance.

What makes Twist Bioscience unique

  • Twist Bioscience uses a silicon-based DNA synthesis platform for precision and scalability.
  • They offer high-quality DNA sequences at competitive prices, attracting diverse clients.
  • Their proprietary platform provides instant feedback on DNA sequence synthesis feasibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Life Insurance

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

-3%
Infor Capital
May 14th, 2025
Atlas Secures $155M for DNA Storage

Atlas has secured a $155 million seed funding round, backed by family offices Tao Capital Partners and Bezos Expeditions, along with ARCH Venture Partners, Deerfield Management, Rsquared VC, Earth Foundry, In-Q-Tel, and others. This investment highlights confidence in Atlas's DNA-based data storage technology. Atlas has also acquired DNA storage assets from Twist Bioscience, positioning it as a leader in the field with its proprietary platform combining semiconductor and enzyme engineering.

Blocks and Files
May 6th, 2025
Twist Bioscience launches Atlas to bring DNA storage to market

Twist Bioscience launches Atlas to bring DNA storage to market.

BioPharmaTrend
May 5th, 2025
Twist Bioscience Spins Out Atlas Data Storage with $155M to Commercialize DNA-Based Data Storage

Twist Bioscience has launched Atlas Data Storage as an independent company focused entirely on the development and commercialization of DNA data storage technologies.

TipRanks
Nov 26th, 2024
Twist Bioscience named a Best Idea for 2025 at TD Cowen

Twist Bioscience named a Best Idea for 2025 at TD Cowen.

SynBioBeta
Oct 31st, 2024
Absci and Twist Bioscience Team Up to Redefine Antibody Discovery with AI

Absci, a pioneer in generative AI-driven drug discovery, and Twist Bioscience, a leader in high-quality synthetic DNA production through its silicon platform, have announced an innovative collaboration to create a novel therapeutic antibody using generative AI.